152 related articles for article (PubMed ID: 11012895)
1. Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
Serradeil-Le Gal C; Raufaste D; Double-Cazanave E; Guillon G; Garcia C; Pascal M; Maffrand JP
Kidney Int; 2000 Oct; 58(4):1613-22. PubMed ID: 11012895
[TBL] [Abstract][Full Text] [Related]
2. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
Serradeil-Le Gal C
Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834
[TBL] [Abstract][Full Text] [Related]
5. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
[TBL] [Abstract][Full Text] [Related]
6. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A
Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059.
Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
Kidney Int; 1996 Aug; 50(2):499-505. PubMed ID: 8840278
[TBL] [Abstract][Full Text] [Related]
8. Selective blockade of vasopressin V2 receptors reveals significant V2-mediated water reabsorption in Brattleboro rats with diabetes insipidus.
Pouzet B; Serradeil-Le Gal C; Bouby N; Maffrand JP; Le Fur G; Bankir L
Nephrol Dial Transplant; 2001 Apr; 16(4):725-34. PubMed ID: 11274265
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
[TBL] [Abstract][Full Text] [Related]
10. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034
[TBL] [Abstract][Full Text] [Related]
11. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
Serradeil-Le Gal C; Wagnon J; Simiand J; Griebel G; Lacour C; Guillon G; Barberis C; Brossard G; Soubrié P; Nisato D; Pascal M; Pruss R; Scatton B; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 2002 Mar; 300(3):1122-30. PubMed ID: 11861823
[TBL] [Abstract][Full Text] [Related]
12. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
14. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.
Gouzénes L; Sabatier N; Richard P; Moos FC; Dayanithi G
J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):771-9. PubMed ID: 10358117
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Johnston CI
Blood Press; 1994 Mar; 3(1-2):137-41. PubMed ID: 8199714
[TBL] [Abstract][Full Text] [Related]
16. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand.
Trinder D; Stephenson JM; Gao X; Phillips PA; Risvanis J; Johnston CI
Peptides; 1991; 12(6):1195-200. PubMed ID: 1815207
[TBL] [Abstract][Full Text] [Related]
17. Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension.
Lacheretz F; Barbier A; Serradeil-Le Gal C; Elena PP; Maffrand JP; Le Fur G
J Ocul Pharmacol Ther; 2000 Jun; 16(3):203-16. PubMed ID: 10872918
[TBL] [Abstract][Full Text] [Related]
18. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579
[TBL] [Abstract][Full Text] [Related]
19. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
20. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]